Globus Medical Inc (GMED) Price to Earnings Ratio

Corporate emblem and logo of Globus Medical Inc (GMED)

Dependence on external component suppliers is mitigated by a strict assembly protocol, as evidenced by the shift in the P/E multiple for Globus Medical, Inc. (GMED), where the indicator remains around 13.90. Stability is driven by the company's leadership in the development of spinal surgery robotics. Meanwhile, the battle for physician loyalty and the risk of startups being acquired by tech giants compel Globus Medical, Inc. (GMED) to continuously invest in unique implants.

NuVasive (GMED) Price to Earnings Ratio: for the period 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for Globus Medical (GMED)

- price and consensus price forecast:
General company analysis:Globus Medical Inc - GMED
Original product of globusmedical.com

The P/E ratio reflects the business value through the relationship between market capitalization and net income, capturing the sensitivity of the market price to operational efficiency and expenses. Stable cash flow from high-margin robotics and surgeon loyalty make Globus Medical, Inc. (GMED) resilient to volatility, allowing the use of P/E valuation to identify entry points at a discount to long-term averages.

Analysis of competing companies

Price to Earnings Ratio BSX|Price to Earnings Ratio EW (Edwards Lifesciences Corporation)|Business Payback Period ResMed Inc.|P/E Multiple PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Market Cap to Net Income|CooperSurgical - P/E Multiple|Market Cap to Net Income ALGN|TMDX: P/E Multiple|Market Cap to Earnings ATEC Spine (ATEC)|AORT (Artivion) - P/E Multiple|Price to Earnings Multiple ENOV (Enovis)|Price to Earnings Ratio IART (Integra LifeSciences Holdings Corporation)|ESTA (Establishment Labs Corp) - Company Value to Net Income|Price to Earnings Ratio iLet Bionic Pancreas BBNX|IRMD - Price to Earnings Ratio|Embecta Corp - P/E Multiple|Market Cap to Earnings Tandem Diabetes Care|AXGN: P/E Multiple|Price to Earnings Multiple SIBN|OFIX (Orthofix Corp) - P/E Multiple|Price to Earnings Ratio Bioventus Corp (BVS)|P/E Multiple KIDS|Price to Earnings Ratio Treace Medical Concepts TMCI|P/E Multiple SRTA (blade.com)|P/E Multiple Carlsmed, Inc. CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis, Inc.) - Price to Earnings Ratio|Neuronetics, Inc. - Company Value to Net Income|SGHT (Sight Sciences Inc) - P/E Multiple|Market Cap to Earnings Orchestra BioMed Inc. OBIO|Price to Earnings Ratio Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Market Cap to Net Income Ratio|Jin Medical International Ltd. - Price to Earnings Ratio|P/E Multiple Vivani VANI|Xtant Medical Holdings, Inc. - P/E Multiple|Business Payback Period NeuroOne NMTC|Modular Medical, Inc. (MODD) - Price to Earnings Ratio|Price to Earnings Ratio Myomo, Inc|Price to Earnings Ratio envoymedical.com|Price to Earnings Ratio Vivos Therapeutics (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical, Inc. TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|Business Payback Period invobioscience.com IVF|BBLG: P/E Multiple|Axonics Modulation Technologies (AXNX) - P/E Multiple|BIOL (Biolase Inc.) - P/E Multiple|Market Cap to Earnings dynatronics.com DYNT|P/E Multiple FNA|Price to Earnings Ratio INVO (INVO Bioscience Inc.)